abstract: Human sperm contain similar amounts of protamine-1 (P1) and protamine-2 (P2). Although an aberrant protamine ratio have been observed in subfertile men, functional evidence is provided by protamine knockout mice exhibiting male infertility. As sperm DNA integrity is known to be linked with DNA fragmentation and apoptosis, we investigated whether the DNA fragmentation factor 40 (DFF40) ratio or caspase (Casp4, Casp6) and tumor necrosis factor superfamily member 10 (TNFSF10) ratio together with the P1/P2 ratio represents a reliable biomarker to discriminate between fertile and subfertile men. Real-time quantitative RT -PCR was used for amplification of P1, P2 and DFF40 in 49 testicular biopsies. Casp4, Casp6 and TNFSF10 have been selected from a PCR apoptosis array and were further investigated in another group of testicular biopsies (22 subfertile men versus 11 potentially fertile men). Using Spearman's rank correlation coefficient analysis, we did not find a correlation between DFF40 and P1, P2, P1/P2, score, fertilization rate and age. In addition, logistic regression analysis demonstrated no statistically significant effect of the analyzed variables on pregnancy. A two-way analysis of variance with repeated measures of relative expression of Casp4, Casp6 and TNFSF10 versus P1 or P2 in potentially fertile men and subfertile patients demonstrated statistically significant differences between both groups, all tested gene combinations and the interaction between two genes and both groups in all cases analyzed. Furthermore, significant differences in the expression of Casp4 and TNFSF10 between the groups of potentially fertile and subfertile men could be demonstrated. In addition, the means of differences of selected gene combinations revealed that the protamine to apoptotic gene ratio is statistically different between both groups. Our data suggest that Casp4, Casp 6 and TNFSF10 are differentially expressed in potentially fertile and subfertile men and represent useful biomarkers for predicting male fertility in combination with P1 and P2.
Introduction
Ejaculated human spermatozoa exhibit a histone to protamine ratio of 20/80 (Tanphaichitr et al., 1978) and a protamine-1 (P1) to protamine-2 (P2) ratio of 50/50 (Balhorn et al., 1988) . Numerous studies demonstrated that male infertility is associated with an abnormal histone to protamine ratio (Zhang et al., 2006) and an aberrant P1 to P2 ratio at both the protein level in ejaculated spermatozoa (Balhorn et al., 1988; Belokopytova et al., 1993; Nasr-Esfahani et al., 2004) and the mRNA level in testicular spermatids (Steger et al., 2001 (Steger et al., , 2003 . Abnormal protein synthesis has been reported to be associated with aberrant mRNA retention, suggesting that defects in protamine translational regulation may contribute to protamine deficiency in infertile men (Aoki et al., 2006) . In addition, a close relationship has been reported between protamine deficiency and DNA integrity (Aoki et al., 2005) , as well as between male infertility and activated apoptosis signaling (Grunewald et al., 2005) . However, increased susceptibility of spermatozoa from infertile patients on pro-apoptotic stimuli may be due to different reasons (Grunewald et al., 2008 (Grunewald et al., , 2009 . Rapid advances in reproductive molecular biology resulted in numerous techniques to assess sperm chromatin quality and DNA fragmentation (reviewed in Evenson et al., 2002; Agarwal and Said, 2003) . The degree of sperm DNA fragmentation reflects the integrity of the genetic material of the gamete representing an important parameter, as many types of DNA lesions induce mutations commonly observed in mutated oncogenes and tumor suppressor genes (Marnett, 2000) . It has been demonstrated that murine caspase-activated DNase (CAD) and inhibitor of CAD (ICAD), a homolog of human DNA fragmentation factor 45 (DFF45), were capable of generating a caspase-3-activated DNase activity that cleaves DNA Shakahira et al., 1998) . Mouse CAD/ ICAD and human DFF40/45, therefore, represent a direct link between caspase activation and DNA fragmentation .
This study aimed at analyzing apoptotic mRNA ratios in testicular biopsies with normal and impaired spermatogenesis in order to investigate whether the apoptotic gene mRNA ratio in combination with the protamine ratio represents a reliable biomarker for the discrimination between fertile and infertile men. We expected high protamine/low apoptotic gene expression in normal spermatogenesis and low protamine/high apoptotic gene expression in impaired spermatogenesis. Using DFF40 as a candidate gene, we analyzed 84 apoptotic genes with an apoptotic PCR array and real-time quantitative PCR to expose further candidate genes that were involved in apoptosis during impaired spermatogenesis.
Materials and Methods

Testicular tissue
All samples have been obtained after patients gave written informed consent. For investigations on DFF40 (group 1), testicular biopsies were obtained from 49 men (aged 25 -62 years) exhibiting normal (spermatogenic scores: 10 -8, n ¼ 28) and impaired (spermatogenic scores: 7 -0, n ¼ 21) spermatogenesis (Bergmann and Kliesch, 2010) . While one part of the biopsy was cryopreserved for testicular sperm extraction, the other part was fixed in Bouin's fixative and embedded in paraffin wax. For histological evaluation, 5 mm paraffin sections were stained in hematoxylin and eosin. For investigations on Casp4, Casp6 and tumor necrosis factor superfamily member 10 (TNFSF10; group 2), testicular biopsies were obtained from 33 men with obstructive and non-obstructive azoospermia undergoing andrological work up for sperm retrieval, according to Pantke et al. (2008) . After hematoxylin-eosin staining, all biopsies were histologically evaluated, according to Bergmann and Kliesch (2010) and classified as normal spermatogenesis (spermatogenic scores: 10 -8, n ¼ 11) or impaired spermatogenesis (spermatogenic scores: 5 -1, n ¼ 22). Nine patients with normal spermatogenesis exhibited obstructive azoospermia.
For the PCR array, we used both a biopsy from a patient (spermatogenic score 3) and RNA from Clontech (Mountain View, CA, USA) as positive control.
All patients used in this study were classified as potentially fertile or subfertile, according to their score values and P1/P2 ratios . In addition, the fertilization rate in IVF/ICSI treatment and reported clinical pregnancies were considered for patients of the DFF40 group with values between 0 and 100%, as published earlier .
Extraction of mRNA
Five paraffin sections (5 mm) were collected in a reaction tube and deparaffinized in 1 ml xylene for 5 min at room temperature. After centrifugation (4 min, 31 500g, 48C), this step was repeated three times. Subsequently, the pellet was resuspended two times in 1 ml of 96% ethanol and centrifuged (4 min, 31 500g, 48C). The pellet was dried for 15 min at 378C. After adding proteinase K to a final concentration of 14 mg/ml and 200 ml lysis buffer (20 mmol Tris, 20 mmol ethylenediaminetetraacetic acid, 2% sodium dodecyl sulfate in diethylpyrocarbonate-H 2 O pH 7.4), samples were vortexed and incubated for 90 min at 568C. Subsequently, 1 ml Trizol has been added and vortexed for 1 min. Samples were then digested overnight at 48C. RNA extraction was performed using TRIzol w Reagent, as recommended by the manufacturer (Life Technologies, Lö hne, Germany). RNA concentrations and quality were determined using a NanoDrop ND-1000 (Peqlab, Erlangen, Germany). DNase digestion was performed using RQ1 RNase-free DNase Kit, as recommended by the manufacturer (Promega, Mannheim, Germany). First-strand cDNA synthesis was performed using iScript cDNA synthesis Kit, according to the manufacturers' protocol (Biorad, Munich, Germany). All products were purified using Nucleotide Removal Kit (Qiagen, Hilden, Germany).
For the PCR array, first-strand cDNA was mixed with a specific RT 2 quantitative PCR Master Mix and aliquoted into each well of a plate containing pre-dispensed gene-specific primer sets.
Real-time PCR and statistical evaluation
Real-time PCR was performed with samples of the first group. Values recorded for quantification were the fractional cycle numbers (C t ), where the background-corrected amplification curves crossed a threshold value. Correlations were tested for the C t -values using Spearman's rank correlation coefficient (r s ) in order to obtain a correlation between DFF40 versus P1, P2, P1/P2, score, capacity of fertilization and age. C t values were then analyzed with a multiple stepwise logistic regression model for their effect on pregnancy by fitting the data to the logistic curve. Spearman's rank correlation coefficient and the logistic model have been done by applying the BMDP Statistical Software Package (Dixon, 1993) . In general, a significance level of P ¼ 0.05 was chosen.
PCR array analysis and statistical evaluation
In addition, we investigated the expression of 84 relevant genes of the human apoptotic pathway (www.sabiosciences.com). Two profiler PCR arrays for apoptosis were performed, according to the manufacturer's instructions (SABiosciences, Frederick, MD, USA), including a human genomic DNA contamination control, a RT control and a positive PCR control. For further real-time RT-PCR data analysis, we used glyceraldehyde-3-phosphatedehydrogenase (GAPDH) as reference gene.
The following primers were designed using Primer 3 software and employed from Eurofins MWG Operon (Ebersberg, Germany). GAPDH (f: 5 ′ TGG TAT CGT GGA AGG ACT CAT GA 3 ′ and r: 5 ′ ATG CCA GTG AGC TTC CCG TTC A 3 ′ ), TNFSF10 (f: 5 ′ TGC AGT CTC TCT GTG TGG CTG 3 ′ and r: 5 ′ CAA GCA ATG CCA CTT TTG GA 3 ′ , according to Mark et al., 2007) , Casp4 (f: 5 ′ TTT CTG CTC TTC AAC GCC ACA 3 ′ and r: 5 ′ AGC TTT GGC CCT TGG AGT TTC 3 ′ ) and Casp6 (f: 5 ′ CCG GCA GTG TCA ACT GTT AG 3 ′ and r: 5 ′ GCA TAA ATGTGA TTGCCT TCG C 3 ′ ). Relative expression levels were calculated using GenEx pro 4.3.7 software (Multid Analyses AB Copyright & ) and transformed to Log 2 scale.
In addition, real-time PCR was performed with samples from the second group, and the means of the relative expression levels of the potentially fertile group (spermatogenic scores: 10 -8) and the subfertile group (spermatogenic scores: 5 -1) were calculated. Furthermore, the relative gene expression in log 2 was analyzed by a two-way analysis of variance (ANOVA) with repeated measures with respect to the expressed genes to compare the mean values between the two groups. This was done with the program BMDP2V. Afterwards, relative expression of the three selected apoptotic genes was examined by two-tailed t-test to test for significant differences in expression levels between the two groups (Multid Analyses AB Copyright & ). Furthermore, differences of relative expression in log 2 of selected gene combinations were analyzed between potentially fertile and subfertile men. The WilcoxonMann-Whitney test was chosen to test for significance due to its deviation from normal distribution (program: BMDP3D).
Results
DFF40 expression
In the present study, we analyzed the mRNA expression of DFF40 in men exhibiting normal (spermatogenic scores: 10 -8) and impaired (spermatogenic scores: 7-0) spermatogenesis and 84 apoptotic candidate genes in both potentially fertile men and subfertile patients in order to detect differences in the expression pattern of these genes between the two groups and to identify a potential apoptotic biomarker. Applying Spearman's rank correlation coefficient analysis, we measured the degree of correlation between DFF40 versus P1, P2, P1/P2, score, fertilization capacity and age. We did not find a correlation between DFF40 and these variables ( Table I) . The logistic regression model results demonstrated no statistically significant effect of the analyzed variables on pregnancy (Table II) .
PCR array analysis
Based on the C t values of the PCR array, we could demonstrate a high difference in the expression of Casp4, Casp6 and TNFSF10 between control and sample. Results of all 84 genes are shown in Table III. Based on these results, we provided a real-time PCR analysis in 11 potentially fertile men (spermatogenic scores: 10 -8) and 22 subfertile patients (spermatogenic scores: 5-1) revealing that Casp4, Casp6 and TNFSF10, as well as P1 and P2 were expressed in both potentially fertile and subfertile patients. In addition, the different expression between Casp4, Casp6 or TNFSF10 and P1 or P2 in potentially fertile men and subfertile patients was examined by a two-way ANOVA with repeated measures. The ANOVA showed that the globally different expression between the two groups was statistically significant for all analyzed gene combinations except for Casp4 versus P2. Differences between the expressions of the tested genes were statistically significant in all cases. Interaction between the gene effects (Casp4, Casp6, TNFSF10 versus P1, P2) and the group effects (potentially fertile versus subfertile) revealed clearly statistically significant differences in all analyzed combinations (Table IV) .
Analysis of the different expression of Casp4, Casp6 or TNFSF10 between potentially fertile men and subfertile patients demonstrated significant differences between the two groups for Casp4 and TNFSF10 [P (two-tailed) values: Casp4: 0.01; Casp6: 0.052; TNFSF10: 0.038].
Correlation between apoptosis markers and protamines
Differences of relative expression (log 2 ) of selected gene combinations (P1-TNFSF10, P1-Casp4, P1-Casp6, P2-TNFSF10, P2-Casp4 and P2-Casp6) were analyzed between potentially fertile and subfertile men. In potentially fertile men, the means of difference between a protamine and an apoptotic gene were 6.1-6.3 for P1 and 5.3-5.5 for P2. In subfertile men, the means of difference were 1.5-2.0 for P1 and 1.1 -1.5 for P2. The values for P2 were lower than the values for P1 in both groups. The Wilcoxon -Mann-Whitney test demonstrated statistically significant differences for all analyzed combinations of gene differences (Table V) .
Discussion
In previous studies, a significant correlation between protamine ratio and successful fertilization has been demonstrated using in situ hybridization (Steger et al., 2001; Mitchell et al., 2005) and qRT-PCR in testicular biopsies (Steger et al., 2003 , as well as western blot analyses on ejaculated spermatozoa (Nasr-Esfahani et al., 2004) . In the present study, we investigated the mRNA expression of DFF40 and 84 apoptotic genes, including Casp4, Casp6 and TNFSF10 in men exhibiting normal and impaired spermatogenesis. Using Spearman's rank correlation coefficient analysis, we measured the degree of correlation between DFF40 versus P1, P2, P1/P2, score, fertilization rate and age. We did not find a correlation between DFF40 and the aforementioned variables. In addition, the logistic regression model results demonstrated no statistically significant effect of the analyzed variables on pregnancy. Our findings suggest that DFF40 is expressed during spermatogenesis and contributes to DNA defragmentation and apoptosis process, as has been reported by Li et al. (2001) , Parrish et al. (2001) , Zhang et al. (1998 Zhang et al. ( , 1999 Zhang et al. ( , 2003 , but does not represent a biological marker for male fertility.
Based on the C t values of the PCR array, we could demonstrate a high difference in the expression of Casp4, Casp6 and TNFSF10 between control and sample. In addition, real-time PCR analysis revealed significant differences in the expression of Casp4 and TNFSF10 between potentially fertile men and subfertile patients.
Caspases, such as Casp4 and Casp6, are cysteine proteases, function as precursors and are activated by dimerization or by proteolytic cleavage after cell death signal triggering (Earnshaw et al., 1999) . In addition, Casp6 was shown to be an important member of executioner caspases, which is expressed in rat testis and several other tissues (Singh et al. , TNFSF10 belongs to the TNF-a superfamily of death ligands, which at present has 19 members and was first identified 20 years ago as a cytokine with antitumor effects in vitro and in vivo (Pennica et al., 1984 , Aggarwal et al., 1985 . It causes inflammatory, antiviral and immunoregulatory effects, stimulates proliferation of normal cells and exerts cytolytic and cytostatic action against tumor cells (Baker and Reddy, 1998) . TNFSF10 (also known as TRAIL) protein is expressed in Leydig cells, spermatocytes and round and elongating spermatids in adult human testis (Grataroli et al., 2004) . Suominen et al. (2004) suggested that the TNF-family promotes cell survival during spermatogenesis. However, in mice, addition of TNFSF10 (0.5 mg/ml) causes a 3-fold increase in germ cell apoptosis, specifically in spermatocytes (McKee et al., 2006) . In the present study, we demonstrated a higher expression of TNFSF10 in impaired than in normal spermatogenesis, which may induce apoptosis in spermatocytes and result in disruption of spermatogenesis.
Furthermore, we could demonstrate that the interaction between two genes (Casp4, Casp6, TNFSF10 versus P1, P2) and both groups (potentially fertile versus subfertile) revealed statistically significant differences in all analyzed combinations, which means that apoptotic gene expression is different from P1 and P2 expression in potentially fertile and subfertile men. In addition, the means of difference between a protamine and an apoptotic gene showed a statistically significant difference between potentially fertile and subfertile men, which indicate that the protamine to apoptotic gene ratio plays a role in proper sperm development. In conclusion, our results suggest that Casp4, Casp6 and TNFSF10 in combination with P1 and P2 represent useful biomarkers for male fertility. 
Table IV
Results of the two-way ANOVA with repeated measures with respect to the measured gene for the relative expression (log 2 scale) of Casp4, Casp6 and TNFSF10 versus P1 or P2 in potentially fertile men (score 10, n 5 11) and subfertile patients (scores 2 -5, n 5 22) (group 2). Description of data by mean and standard deviation (x + + + + + SD). 
